Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 May;13(5):813-9.
doi: 10.1128/AAC.13.5.813.

Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins

Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins

H C Neu et al. Antimicrob Agents Chemother. 1978 May.

Abstract

Synergistic activity between both azlocillin and mezlocillin and aminoglycosides or cefazolin could be demonstrated by checkerboard dilution, isobologram, and killing curve techniques. Azlocillin and mezlocillin combined with gentamicin, netilmicin, or amikacin were synergistic against Escherichia coli, Klebsiella, Citrobacter, Enterobacter, Serratia, and indole-positive Proteus. Synergy was observed with isolates that were susceptible or resistant to azlocillin or mezlocillin. Synergy was seen most often when azlocillin or mezlocillin were combined with amikacin, gentamicin, or netilmicin against Pseudomonas aeruginosa. The combination of mezlocillin and an aminoglycoside produced synergy more often than did carbenicillin plus an aminoglycoside. No antagonism was seen when aminoglycoside antibiotics were combined with azlocillin or mezlocillin. Cefazolin was synergistic against Pseudomonas, Providencia, P. mirabilis, indole-positive Proteus, Citrobacter, Klebsiella, and Escherichia coli, when combined with azlocillin or mezlocillin. However, the combination of either agent with cefazolin was antagonistic when tested against selected indole-positive Proteus and Enterobacter isolates.

PubMed Disclaimer

References

    1. N Engl J Med. 1977 Mar 31;296(13):722-8 - PubMed
    1. N Engl J Med. 1977 Mar 24;296(12):663-70 - PubMed
    1. N Engl J Med. 1977 Apr 7;296(14):784-7 - PubMed
    1. J Infect Dis. 1976 Nov;134(5):476-85 - PubMed
    1. J Antibiot (Tokyo). 1975 Oct;28(10):804-8 - PubMed

MeSH terms

LinkOut - more resources